Reason reporter Billy Binion discusses his coverage of outrageous cases around civil liberties, criminal justice, and government accountability, and the unusual path that led him to journalism.
Economist Jeremy Horpedahl breaks down the economic outlook for Millennials and Gen Z and assesses how the 2024 presidential candidates' policies stack up against reality.
Former NPR and Slate fixture Mike Pesca discusses media meltdowns, objectivity vs. moral clarity, and whether we are better or worse off now that media gatekeepers have less influence.
The host of Why We Can't Have Nice Things returns to discuss the podcast's second season, which focuses on how government makes Americans poorer and sicker.
Legendary musician and writer Nick Cave discusses his forthcoming album Wild God, Roger Waters and the BDS movement, and the role of freedom in seeking transcendence.
The founder of Interintellect, a global online community for intellectual salons, advocates for a truly free and self-moderating market of ideas in the age of political polarization.
The business journalist discusses his new book Go Woke, Go Broke and how CEOs accelerated corporate political activism only to regret its impact on the economy.
The 2024 Libertarian Party presidential candidate speaks out about the Israel-Hamas war, the authoritarian impulses of both Donald Trump and Kamala Harris, and homophobia within his own party.
The filmmakers who brought The Coddling of the American Mind to the big screen discuss the students whose stories inspired the film and the state of the media, Hollywood, and storytelling.
The co-founder of Whole Foods discusses his new memoir, The Whole Story: Adventures in Love, Life, and Capitalism as he launches his new holistic health venture, Love.Life.
The free speech absolutist and co-founder of The Intercept dives deep into Israel, Latin America, and the necessity of decentralized media in the age of U.S. security state overreach.
The head of Students for Sensible Drug Policy clarifies the misconceptions around decriminalization, safe injection sites, and whether Trump or Biden is better on drug policy.